Charles Vestereghem (Charles Vesteghem)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Multiple Myeloma

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Clinical epidemiology

Future oncology (London, England)

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Charles Vestereghem, Martin Bøgsted, Deirdre P Cronin-Fenton, Laurids Østergaard Poulsen
Extracting Systemic Anticancer Treatment Lines from the Danish National Patient Registry for Solid Tumour Patients Treated in the North Denmark Region Between 2009 and 2019. Clinical epidemiology 16 (2024)
Charles Vestereghem, Martin Bøgsted, Deirdre P Cronin-Fenton, Laurids Østergaard Poulsen
Extracting Systemic Anticancer Treatment Lines from the Danish National Patient Registry for Solid Tumour Patients Treated in the North Denmark Region Between 2009 and 2019. Clinical epidemiology 16 (2024)
Morten Ladekarl, Anne Krogh Nøhr, Mads Sønderkær, Simon Christian Dahl, Lone Sunde, Charles Vestereghem, Christophe Kamungu Mapendano, Charlotte Aaquist Haslund, Anja Pagh, Andreas Carus, Tamás Lörincz, Kinga Nowicka-Matus, Laurids Ø Poulsen, René Johannes Laursen, Karen Dybkær, Birgitte Klindt Poulsen, Jens Brøndum Frøkjær, Anja Høegh Brügmann, Anja Ernst, Alkwin Wanders, Martin Bøgsted, Inge Søkilde Pedersen
Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital. Acta oncologica (Stockholm, Sweden) (2023)
Charles Vestereghem, Weronika Maria Szejniuk, Rasmus Froberg Brøndum, Ursula G Falkmer, Chloé-Agathe Azencott, Martin Bøgsted
Dynamic Risk Prediction of 30-Day Mortality in Patients With Advanced Lung Cancer: Comparing Five Machine Learning Approaches. JCO clinical cancer informatics 6 (2022)
Lars Børty, Rasmus Froberg Brøndum, Heidi S Christensen, Charles Vestereghem, Marianne Tang Severinsen, Søren Paaske Johnsen, Lars Holger Ehlers, Ursula Falkmer, Laurids Østergaard Poulsen, Martin Bøgsted
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Mette Thune Mouritzen, Andreas Carus, Morten Ladekarl, Peter Meldgaard, Anders W M Nielsen, Anna Livbjerg, Jacob W Larsen, Halla Skuladottir, Charlotte Kristiansen, Kim Wedervang, Tine Schytte, Karin H Hansen, Anne-Cathrine Østby, Malene S Frank, Jakob Lauritsen, Jens Benn Sørensen, Seppo Wang Langer, Gitte F Persson, Jon L Andersen, Johanna M C Frary, Lars B Drivsholm, Charles Vestereghem, Heidi S Christensen, Birgitte Bjørnhart, Mette Pøhl
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy. Cancers 13 (19) (2021)
Rasmus Froberg Brøndum, Anne Sig Sørensen, Lars Børty, Charles Vestereghem, Anne S Rytter, Marlene M Nielsen, Marianne Tang Severinsen, Paw Jensen, Henrik Gregersen, Tarec Christoffer El-Galaly, Karen Dybkær, Lars Holger Ehlers, Martin Bøgsted, Anne Stidsholt Roug
Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system. Future oncology (London, England) 17 (25) (2021)
Charles Vestereghem, Rasmus Froberg Brøndum, Ursula G Falkmer, Jesper Hallas, Laurids Østergaard Poulsen, Martin Bøgsted
High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019. Clinical epidemiology 13 (2021)